Filter byLast updated dateSelectAfterBeforeFrom - ToDateEnd DateThis weekThis monthLast weekLast monthCategoryHumanCorporateVeterinaryHerbalTopicMedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesCorporateEarly accessFeesProduct informationMedicines for use outside the EUMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurementDiseases areaViral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDSResponsible bodyCHMPCVMPPRACManagement BoardCOMPPDCOCMDhHMPCCATPatient safetyYesLeave this field blankFiltersResults (3750) Sort byLast update date (new to old)Last update date (old to new)A-ZZ-ALeave this field blankMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 October 2023 NewsVeterinaryMedicinesEMA Management Board: highlights of October 2023 meeting 6 October 2023 NewsCorporateRevised transparency rules for the EU Clinical Trials Information System (CTIS) 6 October 2023 NewsEMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 October 2023 NewsHumanMedicinesMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023 NewsHumanPharmacovigilanceReferralsEMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023 NewsHumanMedicinesTowards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023 NewsHumanMeeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023 NewsHumanCOVID-19MedicinesReferralsSpikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 September 2023 NewsHumanCOVID-19MedicinesPRAC recommends new measures to avoid topiramate exposure in pregnancy 1 September 2023 NewsHumanReferralsPrevious181920212223242526Next
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 3-5 October 2023 6 October 2023 NewsVeterinaryMedicines
EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna 5 October 2023 NewsHumanMedicines
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 25-28 September 2023 29 September 2023 NewsHumanPharmacovigilanceReferrals
EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep 28 September 2023 NewsHumanMedicines
Towards a permanent collaboration framework for EMA and Health Technology Assessment bodies 15 September 2023 NewsHuman
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 15 September 2023 NewsHumanCOVID-19MedicinesReferrals
Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 14 September 2023 NewsHumanCOVID-19Medicines
PRAC recommends new measures to avoid topiramate exposure in pregnancy 1 September 2023 NewsHumanReferrals